In CLL, circ-CBFB, derived from the CBFB transcript, has been reported to be an independent prognosis factor in CLL patients, and is highly upregulated in this cohort compared to healthy donors [47]. Here, CBFB is linked to B-cell chronic lymphocytic leukemia.